| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Molecular and Cellular Biology, April 2007, p. 2582-2589, Vol. 27, No. 7
0270-7306/07/$08.00+0 doi:10.1128/MCB.01722-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
,
Department of Animal Biology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104,1 Center for Research on Reproduction and Women's Health, Department of Obstetrics and Gynecology, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104,2 Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/ULP, 1 Rue Laurent Fries, 67404 Illkirch Cédex, France,3 Howard Hughes Medical Institute, Whitehead Institute, and Department of Biology, Massachusetts Institute of Technology, 9 Cambridge Center, Cambridge, Massachusetts 021424
Received 12 September 2006/ Returned for modification 30 October 2006/ Accepted 8 January 2007
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Strikingly, studies of a number of tissue-specific TAFs in Drosophila melanogaster and mouse have identified cell-type-specific transcription programs. In Drosophila melanogaster, five testis-specific homologues of widely expressed TAFs have been reported: Can (homologue of dTAF5), Nht (homologue of dTAF4), Mia (homologue of dTAF6), Sa (homologue of dTAF8), and Rye (homologue of dTAF12) (18, 19). Null mutations in can, nht, mia, and sa result in the same male sterile phenotype, and all four genes are required for meiotic cell cycle progression and onset of spermatid differentiation (27). In addition, Rye interacts with Nht, suggesting that these five testis-specific TAFs in Drosophila function in the same transcription regulatory pathway (18). Mechanistically, these TAFs may counteract transcriptional repression by Polycomb group (PcG) proteins in spermatocytes (8). In mice, TAF4B (homologue of TAF4) is highly expressed in the testis and the granulosa cells of the ovary, where it is required for follicular development (14). Testes of TAF4B-deficient males are initially normal but undergo progressive germ cell loss, resulting in male sterility by 3 months of age (12). In addition to tissue-restricted TAFs, TRF2 is a testis-specific homologue of TBP and is essential for spermiogenesis in mouse (28, 44). These results, together with other studies, support the presence of tissue-specific transcription programs in regulating germ cell differentiation (23, 33).
We have identified a testis-specific homologue of the generally expressed TAF7 in mouse, named TAF7L (30, 39). TAF7 interacts with multiple transcription activators (9). TAF7 also interacts with other TAFs, including TAF1 (the largest subunit of TFIID), but not with TAF10 or TBP (9, 24). Binding of TAF7 to TAF1 inhibits the acetyltransferase activity of TAF1, which is important for the transcription of major histocompatibility complex class I genes (16). Like TAF7 in somatic tissues, TAF7L interacts with TAF1 and is associated with TBP in testes, indicating that TAF7L is a bona fide TAF (30). Subcellular localization of TAF7L in male germ cells is dynamic. TAF7L is cytoplasmic in spermatogonia and early spermatocytes (preleptotene, leptotene, and zygotene); however, TAF7L translocates into the nuclei of pachytene spermatocytes and round spermatids. In contrast, TAF7 is nuclear from spermatogonia to pachytene spermatocytes and appears to be absent in round spermatids. Biochemical studies indicate that TAF7L might replace TAF7 in the TFIID complex to modulate the transcription program in spermatogenesis (30). To assess the role of TAF7L in spermatogenesis, we generated mice lacking TAF7L by gene targeting in embryonic stem (ES) cells. Here, we describe the effects of this mutation on gene transcription and production, morphology, and motility of spermatozoa.
| MATERIALS AND METHODS |
|---|
|
|
|---|
|
Two Taf7l3lox-positive ES cell clones were then electroporated with the pOG231 plasmid that transiently expresses Cre recombinase. Two days after electroporation, cells were passaged and then subjected to selection with ganciclovir (2 µM; Sigma) for removal of the HyTK cassette. Viable colonies were picked and screened by PCR. Recombination between the HyTK-flanking loxP sites resulted in the Taf7lflox allele at a frequency of 12.5% (see Fig. 2A).
Generation and genotyping of mice. ES cells harboring the Taf7lflox allele were injected into BALB/c blastocysts that were subsequently transferred to uteri of pseudopregnant Swiss Webster females. The resulting male chimeras were bred with BALB/c females to obtain germ line transmission of injected ES cells. Agouti females were genotyped by PCR. Taf7lflox mice were crossed with ACTB-Cre transgenic mice to obtain the Taf7l (mutant) allele (26). The ACTB-Cre transgene was subsequently removed from Taf7l mutant mice by breeding. We backcrossed Taf7l+/ mice to C57BL/6J (B6) and 129 strains for more than five generations (strain 129X1/SvJ, stock no. 000691; The Jackson Laboratory). Mice from either B6 or 129 backgrounds were used in this study. All offspring were genotyped by PCR. Wild-type (300-bp) and flox (490-bp) alleles were assayed by PCR with the primers CCATTCTTCTAAATCCCTAGC and TCGCTTGGGAACTCATCAATT. The PCR product (218 bp) of the mutant allele was amplified by PCR with the primers CCATTCTTCTAAATCCCTAGC and CATCGTGTAATTTGGGTTGAC.
Coimmunoprecipitation and Western blot analysis. Nuclear extracts from testes were prepared as previously described (30). Extracted proteins (10 µg) were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and the presence of TBP, TAF7, and TAF7L was revealed using monoclonal antibodies 3G3, 19TA, and 46TA as previously described (6, 30). The filters were then reprobed with antibodies against TAF5 and TAF6 (4, 10). Immunoprecipitations were performed as previously described (30). Briefly, 200 µg of extract was immunoprecipitated with anti-TBP antibody (3G3) overnight at 4°C with 100 µl of protein G-Sepharose. Beads were washed three times for 10 min at room temperature with buffer A (20% glycerol, 50 mM Tris-HCl, pH 7.9, 1 mM EDTA, 1 mM dithiothreitol, 0.1% NP-40) containing 0.5 M KCl and once with buffer A containing 0.1 M KCl. Precipitated material was eluted using a peptide against the 3G3 epitope as described previously (6). Eluted proteins were probed on immunoblots using the antibodies described above.
EM and histology. Electron microscopy (EM) was performed at the Biomedical Imaging Core Facility at the University of Pennsylvania as previously described (42). Cauda epididymides from 8-week-old wild-type and Taf7l/Y mice were fixed and processed for EM. For histological analysis, testes were fixed in Bouin's solution, embedded in paraffin, sectioned, and stained with hematoxylin and eosin as described previously (32).
Sperm count. Cauda epididymides were dissected and minced in phosphate-buffered saline solution. Sperm were squeezed out with fine forceps and allowed to disperse in phosphate-buffered saline at room temperature for 10 min, followed by repeated pipetting. Samples were fixed in 4% paraformaldehyde. Sperm were counted using a hematocytometer. Sperm counting was performed four times for each sample.
Sperm motility assay. Uncapacitated cauda epididymal sperm from wild-type and Taf7l/Y mice were collected by placing minced cauda epididymides in Krebs-Ringer bicarbonate medium (HM) without Ca2+, bovine serum albumin, and NaHCO3 as previously described (25). The working "complete" medium was prepared by adding CaCl2 (1.7 mM), pyruvate (1 mM), NaHCO3 (25 mM), and bovine serum albumin (3 mg/ml), followed by gassing with 5% CO2 and 95% O2 to pH 7.3. One drop of the sperm suspension was transferred to the incubation chamber at 37°C. The incubation time for capacitation was 1 hour at 37°C in a 5% CO2-95% O2 incubator. Aliquots of each sperm suspension were loaded into a 100-µm-deep chamber prewarmed at 37°C (Conception Technologies). Sperm motility parameters were quantified using a computer-assisted semen analysis system running IVOS (version 12.2L; Hamilton Thorne Research). At least 400 sperm per sample were analyzed. For statistical analysis, eight motion parameters, motility, average path velocity (VAP), straight-line velocity (VSL), curvilinear velocity (VCL), amplitude of lateral head displacement, beat-cross frequency (BCF), straightness, and linearity, were examined (see Table 2). For statistical testing, sperm motility measurements of each parameter were pooled for each genotype and for time of observation. Considering the log-normal distribution, Student's t test for independent observations was applied to define differences between the wild type and the mutant in VAP, VSL, VCL, and BCF means (normalized by natural logarithms). For the same purpose, the nonparametric amplitude of lateral head displacement and STR distributions were tested by Friedman's analysis of variance. Statistical analyses were performed using the InStat program (GraphPad software).
|
Quantitative and semiquantitative reverse transcription (RT)-PCR analyses. Total RNA was isolated from 8-week-old wild-type and Taf7l/Y testes by using TRIzol reagent. One microgram of total RNA for each sample was converted into cDNA by reverse transcription with oligo(dT)18V primers and was diluted to a final volume of 200 µl, 5 µl of which was used in each PCR. Three replicates were used for each real-time PCR. Reverse transcriptase-negative templates served as controls. Real-time PCR was run on a LightCycler (Roche). Quantification was normalized to Actb within the log phase of the amplification curve.
Spermatogenic cell populations enriched for specific germ cell types were the same as previously used, and their preparations have been described previously (41). Each enriched population contained a small amount of developmentally adjacent germ cells. A semiquantitative RT-PCR technique was used as previously described (41). Briefly, 70 ng of poly(A)+ RNA was used for reverse transcription primed with oligo(dT)18V in a 25-µl reaction mixture. Each RT reaction was diluted to a total volume of 200 µl, and 5 µl was used for each PCR. To avoid saturation of PCR, products were taken after various cycles (20-30) and analyzed by gel electrophoresis. One microgram of total RNA from adult wild-type and XXY* testes was used for reverse transcription. Controls without reverse transcriptase were negative (data not shown). The following gene-specific primers were used: Actb, AGAAGAGCTATGAGCTGCCT and TCATCGTACTCCTGCTTGCT; Fscn1, ACCGATCAGGAGACCTTCCA and GAGTCTTTGATGTTGTAGGCG; 4732473B16Rik, TGAGCTGGCCACAGGTGAA and ACTTTGACCAGCTTCTGCAC; Cpa6, GAACCAGAAGTGAAGGCTGT and CTTTAGCAGGTGCATTGTGAT; Adc, GGGGTCTTCAACTCAGTCCT and ACAAGGTGTCTGTGATCTCC; D1Ertd622e, AACTTGCACAGTGACATCATC and AGTCCCGTGTCCAGCTGTTT; and Sfmbt2, GACGGATGTGGTACGATTCA and GTGCTCCTTCCGTGTGCTTT. Primers for Pgk2 and Prm1 have been described previously (43).
Microarray data accession number. Microarray tabular data have been deposited in the Gene Expression Omnibus database under accession no. GSE5510.
| RESULTS |
|---|
|
|
|---|
|
Inactivation of the Taf7l gene. To elucidate the role of Taf7l in spermatogenesis, we generated a floxed Taf7l conditional allele (Taf7lflox) in mice (Fig. 2A). Taf7lflox/Y males and Taf7lflox/flox females displayed normal fertility. By crossing with ACTB-Cre transgenic mice, we obtained Taf7l/Y mice that lack exons 2 to 6 (26). Deletion of exons 2 to 6 (amino acids [aa] 96 to 263) resulted in a frameshift. In ACTB-Cre mice, Cre recombinase is under the control of the human ß-actin promoter and is widely expressed. In the hybrid genetic backgrounds, both Taf7l/Y males and Taf7l/ females were fertile and the litter sizes were similar to that of wild-type controls. We backcrossed this knockout allele to C57BL/6 and 129 backgrounds (at least five backcrosses). All subsequent analyses were performed on both C57BL/6 and 129 mice, and no difference was observed. Western blot analysis showed that the TAF7L protein is absent in Taf7l/Y testes (Fig. 2C). In contrast, the abundance of TAF7 is not affected in Taf7l/Y testes.
Expression of TFIID components in Taf7l/Y testes. Two independent nuclear extracts made from wild-type or mutant testes were analyzed for the expression of TFIID components (Fig. 3). Our results showed that no significant change in expression of TBP or the other TAFs (TAF5 and TAF6) was observed in Taf7l/Y testes (Fig. 3A). Nuclear extracts were immunoprecipitated with antibodies against TBP. As expected, TAF7L was coimmunoprecipitated with TBP from wild-type but not Taf7l/Y testes (Fig. 3B). As previously described, little TAF7 was precipitated with TBP in the wild type, whereas a significantly larger amount was found in the immunoprecipitated fraction from Taf7l/Y testes (Fig. 3B) (30). These results suggest that there is competition between TAF7 and TAF7L for integration into TFIID so that in the presence of TAF7L, TAF7 is excluded, whereas in its absence, TAF7 can more readily associate with TBP. However, TAF7 did not appear to be upregulated in Taf7l-deficient spermatids (see Fig. S1 in the supplemental material).
|
|
|
|
Altered gene expression in Taf7l/Y testes. To identify genes with altered expression in Taf7l/Y testes systematically, we performed transcript profiling of testes from 8-week-old mice using Affymetrix Mouse Genome 430 2.0 GeneChips, representing more than 39,000 transcripts. With an expression cutoff of twofold change or greater, our microarray analysis identified 16 genes that were downregulated in Taf7l/Y testes. Quantitative PCR analysis validated the downregulation of six genes (out of 16) in Taf7l/Y testes, including four genes with known functions or motifs (Cpa6, 2.7-fold; Adc, 2.4-fold; Sfmbt2, 2.3-fold; and Fscn1, 3.4-fold) and two genes of unknown function (Table 3). CPA6 and ADC are metabolic enzymes. SFMBT2 (sex comb-like with four mbt domains 2) is a PcG protein and thus a putative transcription factor. Interestingly, FSCN1 is a widely expressed actin-bundling protein involved in cell motility (1). FSCN3, a testis-specific paralogue of FSCN1, localizes specifically to the elongating spermatid head (34). However, the expression of Fscn3 is not altered in Taf7l/Y testes, as assayed by both microarray and quantitative PCR analyses.
|
|
| DISCUSSION |
|---|
|
|
|---|
Recent studies support the notion that special transcription mechanisms operate in germ cells (23, 33). Apart from the presence of testis-specific TAFs, TRF2/TLF is a testis-specific paralogue of TBP. Disruption of Trf2 in mice causes spermiogenic arrest and thus male sterility (28, 44). In comparison, the loss of TAF7L results in reduced fertility but not sterility. Although TAF7L is missing from TFIID, only a small number of genes are affected. The relatively mild phenotypes caused by the loss of TAF7L are surprising. However, the enhanced reproductive fitness (increased sperm count, increased sperm motility, and increased litter size) conferred by Taf7l in one generation has probably had dramatic cumulative effects on an evolutionary time scale.
The transcript levels of six genes are reduced in Taf7l/Y testis more than twofold. The deficiency of Taf7l might be compensated in part but not fully by Taf7, suggesting that Taf7l has evolved specialized functions in transcription regulation in spermatogenesis. It is possible that developmental stage-specific transcripts might be missed by the microarray profiling of whole testes. However, the altered transcript levels of these six genes might be implicated in the sperm defects (amount, morphology, and motility) in Taf7l/Y mice. The most strongly downregulated gene is Fscn1 (Table 3). FSCN1 is a filamentous actin (F actin)-bundling protein involved in cytoplasmic protrusion and cell motility (1). In mammalian spermatozoa, actin filaments are found primarily in the subacrosomal space along the nucleus (37). The actin cytoskeleton undergoes dynamic changes in sperm capacitation and the acrosome reaction (5). Globular actin polymerizes to form F actin during capacitation. Prior to the acrosome reaction, F actin undergoes depolymerization. Actin is also detected in the outer dense fibers of the sperm tail, suggesting that actin may regulate sperm motility (3, 13, 29). We postulate that altered expression of Fscn1 contributes to reduced sperm motility and folding of sperm tails in Taf7l/Y testes. In addition, mutant sperm motility is further reduced upon capacitation (Table 2). These results suggest that bundling of F actin is important for the regulation of sperm motility and capacitation. However, the mechanism underlying FSCN1 function in spermatozoa remains to be determined. In addition, the expression of two metabolic enzymes (CPA6 and ADC) in spermatids might also be related to sperm function (Fig. 6).
In Drosophila, testis-specific TAFs oppose transcriptional repression mediated by PcG proteins, and both groups of proteins localize to the nucleolus in spermatocytes (8). Interestingly, Sfmbt2 encodes a PcG protein of unknown function and is downregulated in Taf7l/Y testes. In addition to nuclear localization in pachytene spermatocytes and round spermatids, TAF7L localizes to specific chromatin domains in meiotically dividing spermatocytes (30). These results suggest that cross talk between testis-specific TAFs and PcG proteins in the regulation of gene-selective transcription in male germ cell differentiation might be conserved between Drosophila species and mice.
Here, we show that targeted disruption of Taf7l in mice results in reduced sperm count and motility. Taf7l is an X-linked, single-copy testis-specific gene in both mice and humans (39). Thus, the human TAF7L gene may also play an important role in spermatogenesis. Because of the hemizygous state of the X chromosome in men, mutations in TAF7L might cause oligozoospermia (reduced sperm count) in humans.
| ACKNOWLEDGMENTS |
|---|
This study was supported by the University of Pennsylvania Research Foundation and NIH/NICHD grant HD 045866 (P.J.W.), NIH grant 1-R01-HD41552 (G.L.G.), Fogarty International Center grant NIH 5-D43-TW 00671 (M.G.B.), and the Howard Hughes Medical Institute (D.C.P). Work at the IGBMC (I.D) was supported by grants from the CNRS, the INSERM, the Fondation pour la Recherche Médicale, the Ministère de la Recherche et de la Technologie, the European Union RTN-00026, the Association pour la Recherche contre le Cancer, and the Ligue Nationale contre le Cancer. M.K. was a recipient of a fellowship from the Fondation pour la Recherche Médicale.
| FOOTNOTES |
|---|
Published ahead of print on 22 January 2007. ![]()
Supplemental material for this article may be found at http://mcb.asm.org/. ![]()
| REFERENCES |
|---|
|
|
|---|
2. Albright, S. R., and R. Tjian. 2000. TAFs revisited: more data reveal new twists and confirm old ideas. Gene 242:1-13.[CrossRef][Medline]
3. Aumüller, G., and J. Seitz. 1988. Immunocytochemical localization of actin and tubulin in rat testis and spermatozoa. Histochemistry 89:261-267.[CrossRef][Medline]
4. Bell, B., E. Scheer, and L. Tora. 2001. Identification of hTAF(II)80 delta links apoptotic signaling pathways to transcription factor TFIID function. Mol. Cell 8:591-600.[CrossRef][Medline]
5. Breitbart, H., G. Cohen, and S. Rubinstein. 2005. Role of actin cytoskeleton in mammalian sperm capacitation and the acrosome reaction. Reproduction 129:263-268.
6. Brou, C., S. Chaudhary, I. Davidson, Y. Lutz, J. Wu, J. M. Egly, L. Tora, and P. Chambon. 1993. Distinct TFIID complexes mediate the effect of different transcriptional activators. EMBO J. 12:489-499.[Medline]
7. Camacho, J. A., N. Rioseco-Camacho, D. Andrade, J. Porter, and J. Kong. 2003. Cloning and characterization of human ORNT2: a second mitochondrial ornithine transporter that can rescue a defective ORNT1 in patients with the hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, a urea cycle disorder. Mol. Genet. Metab. 79:257-271.[CrossRef][Medline]
8. Chen, X., M. Hiller, Y. Sancak, and M. T. Fuller. 2005. Tissue-specific TAFs counteract Polycomb to turn on terminal differentiation. Science 310:869-872.
9. Chiang, C. M., and R. G. Roeder. 1995. Cloning of an intrinsic human TFIID subunit that interacts with multiple transcriptional activators. Science 267:531-536.
10. Dubrovskaya, V., A. C. Lavigne, I. Davidson, J. Acker, A. Staub, and L. Tora. 1996. Distinct domains of hTAFII100 are required for functional interaction with transcription factor TFIIF beta (RAP30) and incorporation into the TFIID complex. EMBO J. 15:3702-3712.[Medline]
11. Eggan, K., H. Akutsu, J. Loring, L. Jackson-Grusby, M. Klemm, W. M. Rideout III, R. Yanagimachi, and R. Jaenisch. 2001. Hybrid vigor, fetal overgrowth, and viability of mice derived by nuclear cloning and tetraploid embryo complementation. Proc. Natl. Acad. Sci. USA 98:6209-6214.
12. Falender, A. E., R. N. Freiman, K. G. Geles, K. C. Lo, K. Hwang, D. J. Lamb, P. L. Morris, R. Tjian, and J. S. Richards. 2005. Maintenance of spermatogenesis requires TAF4b, a gonad-specific subunit of TFIID. Genes Dev. 19:794-803.
13. Fouquet, J. P., M. L. Kann, and J. P. Dadoune. 1990. Immunoelectron microscopic distribution of actin in hamster spermatids and epididymal, capacitated and acrosome-reacted spermatozoa. Tissue Cell 22:291-300.[CrossRef][Medline]
14. Freiman, R. N., S. R. Albright, S. Zheng, W. C. Sha, R. E. Hammer, and R. Tjian. 2001. Requirement of tissue-selective TBP-associated factor TAFII105 in ovarian development. Science 293:2084-2087.
15. Frontini, M., E. Soutoglou, M. Argentini, C. Bole-Feysot, B. Jost, E. Scheer, and L. Tora. 2005. TAF9b (formerly TAF9L) is a bona fide TAF that has unique and overlapping roles with TAF9. Mol. Cell. Biol. 25:4638-4649.
16. Gegonne, A., J. D. Weissman, and D. S. Singer. 2001. TAFII55 binding to TAFII250 inhibits its acetyltransferase activity. Proc. Natl. Acad. Sci. USA 98:12432-12437.
17. Green, M. R. 2000. TBP-associated factors (TAFIIs): multiple, selective transcriptional mediators in common complexes. Trends Biochem. Sci. 25:59-63.[CrossRef][Medline]
18. Hiller, M., X. Chen, M. J. Pringle, M. Suchorolski, Y. Sancak, S. Viswanathan, B. Bolival, T. Y. Lin, S. Marino, and M. T. Fuller. 2004. Testis-specific TAF homologs collaborate to control a tissue-specific transcription program. Development 131:5297-5308.
19. Hiller, M. A., T. Y. Lin, C. Wood, and M. T. Fuller. 2001. Developmental regulation of transcription by a tissue-specific TAF homolog. Genes Dev. 15:1021-1030.
20. Hochheimer, A., and R. Tjian. 2003. Diversified transcription initiation complexes expand promoter selectivity and tissue-specific gene expression. Genes Dev. 17:1309-1320.
21. Hunt, P. A., and E. M. Eicher. 1991. Fertile male mice with three sex chromosomes: evidence that infertility in XYY male mice is an effect of two Y chromosomes. Chromosoma 100:293-299.[CrossRef][Medline]
22. Khil, P. P., B. Oliver, and R. D. Camerini-Otero. 2005. X for intersection: retrotransposition both on and off the X chromosome is more frequent. Trends Genet. 21:3-7.[CrossRef][Medline]
23. Kimmins, S., N. Kotaja, I. Davidson, and P. Sassone-Corsi. 2004. Testis-specific transcription mechanisms promoting male germ-cell differentiation. Reproduction 128:5-12.
24. Lavigne, A. C., G. Mengus, M. May, V. Dubrovskaya, L. Tora, P. Chambon, and I. Davidson. 1996. Multiple interactions between hTAFII55 and other TFIID subunits. Requirements for the formation of stable ternary complexes between hTAFII55 and the TATA-binding protein. J. Biol. Chem. 271:19774-19780.
25. Lee, M. A., and B. T. Storey. 1986. Bicarbonate is essential for fertilization of mouse eggs: mouse sperm require it to undergo the acrosome reaction. Biol. Reprod. 34:349-356.[Abstract]
26. Lewandoski, M., E. N. Meyers, and G. R. Martin. 1997. Analysis of Fgf8 gene function in vertebrate development. Cold Spring Harbor Symp. Quant. Biol. 62:159-168.[Medline]
27. Lin, T. Y., S. Viswanathan, C. Wood, P. G. Wilson, N. Wolf, and M. T. Fuller. 1996. Coordinate developmental control of the meiotic cell cycle and spermatid differentiation in Drosophila males. Development 122:1331-1341.[Abstract]
28. Martianov, I., G. M. Fimia, A. Dierich, M. Parvinen, P. Sassone-Corsi, and I. Davidson. 2001. Late arrest of spermiogenesis and germ cell apoptosis in mice lacking the TBP-like TLF/TRF2 gene. Mol. Cell 7:509-515.[CrossRef][Medline]
29. Paranko, J., A. Yagi, and M. Kuusisto. 1994. Immunocytochemical detection of actin and 53 kDa polypeptide in the epididymal spermatozoa of rat and mouse. Anat. Rec. 240:516-527.[CrossRef][Medline]
30. Pointud, J. C., G. Mengus, S. Brancorsini, L. Monaco, M. Parvinen, P. Sassone-Corsi, and I. Davidson. 2003. The intracellular localisation of TAF7L, a paralogue of transcription factor TFIID subunit TAF7, is developmentally regulated during male germ-cell differentiation. J. Cell Sci. 116:1847-1858.
31. Roeder, R. G. 1996. The role of general initiation factors in transcription by RNA polymerase II. Trends Biochem. Sci. 21:327-335.[CrossRef][Medline]
32. Russell, L. D., R. A. Ettlin, A. P. Sinha Hikim, and E. D. Clegg. 1990. Histological and histopathological evaluation of the testis. Cache River Press, Clearwater, FL.
33. Sassone-Corsi, P. 2002. Unique chromatin remodeling and transcriptional regulation in spermatogenesis. Science 296:2176-2178.
34. Tubb, B., D. J. Mulholland, W. Vogl, Z. J. Lan, C. Niederberger, A. Cooney, and J. Bryan. 2002. Testis fascin (FSCN3): a novel paralog of the actin-bundling protein fascin expressed specifically in the elongate spermatid head. Exp. Cell Res. 275:92-109.[CrossRef][Medline]
35. Veenstra, G. J., and A. P. Wolffe. 2001. Gene-selective developmental roles of general transcription factors. Trends Biochem. Sci. 26:665-671.[CrossRef][Medline]
36. Verrijzer, C. P., and R. Tjian. 1996. TAFs mediate transcriptional activation and promoter selectivity. Trends Biochem. Sci. 21:338-342.[CrossRef][Medline]
37. Vogl, A. W., K. Genereux, and D. C. Pfeiffer. 1993. Filamentous actin detected in rat spermatozoa. Tissue Cell 25:33-48.[CrossRef][Medline]
38. Wang, P. J. 2004. X chromosomes, retrogenes and their role in male reproduction. Trends Endocrinol. Metab. 15:79-83.[CrossRef][Medline]
39. Wang, P. J., J. R. McCarrey, F. Yang, and D. C. Page. 2001. An abundance of X-linked genes expressed in spermatogonia. Nat. Genet. 27:422-426.[CrossRef][Medline]
40. Wang, P. J., and D. C. Page. 2002. Functional substitution for TAFII250 by a retroposed homolog that is expressed in human spermatogenesis. Hum. Mol. Genet. 11:2341-2346.
41. Wang, P. J., D. C. Page, and J. R. McCarrey. 2005. Differential expression of sex-linked and autosomal germ-cell-specific genes during spermatogenesis in the mouse. Hum. Mol. Genet. 14:2911-2918.
42. Yang, F., R. Fuente De La, N. A. Leu, C. Baumann, K. J. McLaughlin, and P. J. Wang. 2006. Mouse SYCP2 is required for synaptonemal complex assembly and chromosomal synapsis during male meiosis. J. Cell Biol. 173:497-507.
43. Yang, F., H. Skaletsky, and P. J. Wang. 2007. Ubl4b, an X-derived retrogene, is specifically expressed in post-meiotic germ cells in mammals. Gene Expr. Patterns 7:131-136.[CrossRef][Medline]
44. Zhang, D., T. L. Penttila, P. L. Morris, M. Teichmann, and R. G. Roeder. 2001. Spermiogenesis deficiency in mice lacking the Trf2 gene. Science 292:1153-1155.
45. Zhou, T., and C. M. Chiang. 2001. The intronless and TATA-less human TAF(II)55 gene contains a functional initiator and a downstream promoter element. J. Biol. Chem. 276:25503-25511.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|